As expected, the DUBm-specific accessory protein Ataxin 7 Like 3 (ATXN7L3) was significantly correlated with a poor survival outcome (Fig. 6A) and stemness properties (Fig. 6B) in BLBC and HER2+-BC biopsies. Here, ERBB2 is linked to breast cancer.